Neurostimulation | sciencenewsnet.in

Breaking News

It’s easier now to treat opioid addiction with medication — but use has changed little

Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

A new report from the American Lung Association shows nearly 40% of people across the U.S. are living in areas that are heavily polluted.

Five facilities at Argonne where climate solutions are front and center

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

For Immigrants to Canada, Risk of MS Increases with Proportion of Life Spent There

Sweet potato quality analysis is enhanced with hyperspectral imaging and AI

The Medical Minute: Supervised exercise therapy eases symptoms of peripheral artery disease

Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients

A university lecture, with a dash of jumping jacks

25 Apr, 2024

Magnetic Microcoils Unlock Targeted Single-Neuron Therapies for Neurodegenerative Disorders

April 23, 2024 sarah JonasResearch Results

In the Journal of Vacuum Science & Technology A, researchers deploy an array of microscopic coils to create a magnetic field and stimulate individual neurons. The magnetic field can induce an electric field in any nearby neurons, the same effect created by an electrode but much more precise. They used an array of eight coils, which combined can induce electric fields using much less current per coil, and employed soft magnetic materials, which boost the magnetic strength of the coils. The researchers constructed a prototype of their coil array, called MagPatch, and encapsulated it within a biocompatible coating.

Magnus Medical Launches with Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

October 29, 2021 sarah JonasResearch Results

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.